Quality-of-Life Effects of Prophylactic Salpingo-Oophorectomy Versus Gynecologic Screening Among Women at Increased Risk of Hereditary Ovarian CancerJoanna B. Madalinska, Neil K. Aaronson, Judith Hollenstein et al.|Journal of Clinical Oncology|2005Cited by 239
The Impact of Hormone Replacement Therapy on Menopausal Symptoms in Younger High-Risk Women After Prophylactic Salpingo-OophorectomyJoanna B. Madalinska, Neil K. Aaronson, Marc van Beurden et al.|Journal of Clinical Oncology|2006Cited by 215
Predictors of Prophylactic Bilateral Salpingo-Oophorectomy Compared With Gynecologic Screening Use in <i>BRCA1/2</i> Mutation CarriersJoanna B. Madalinska, Neil K. Aaronson, Marian J.E. Mourits et al.|Journal of Clinical Oncology|2007Cited by 77
Hormone replacement therapy after risk-reducing salpingo-oophorectomy minimises endocrine and sexual problems: A prospective studyR. F. M. Vermeulen, Neil K. Aaronson, Marc van Beurden et al.|European Journal of Cancer|2017Cited by 50
The Paget Trial: A Multicenter, Observational Cohort Intervention Study for the Clinical Efficacy, Safety, and Immunological Response of Topical 5% Imiquimod Cream for Vulvar Paget DiseaseM. van der Linden, Joanne A. de Hullu, K.A.P. Meeuwis et al.|JMIR Research Protocols|2017Cited by 29